Johnson & Johnson knew for decades that its baby powder contained asbestos, according to a Reuters report published on Friday morning. From at least 1971 to the early 2000s, the company’s raw talc and finished powders sometimes tested positive for small amounts of asbestos, according to documents turned over due to lawsuits. However, executives did not report it to federal regulators. (Reuters)

An appeals court has ordered Purdue Pharma to release secret records about the marketing of its opioid OxyContin. The records include a deposition from Richard Sackler, former president of Purdue; marketing strategies and internal emails about them; internal analyses of clinical trials; settlement communications from another case regarding OxyContin marketing; and information about how sales representatives marketed the drug. (STAT)

The FDA withdrew a proposed rule that would have exposed generic drugmakers to liability over drug safety. The rule, proposed in 2013, would have allowed people to sue generic drugmakers over the side effects of medicines. The rule raised questions about whether generic drug companies could change their labels to reflect new safety concerns. (Wall Street Journal)

A court blocked Trump administration rules that allowed many employers to opt out of providing free birth control to employees by claiming religious objections. The lawsuit claimed those changes were made without the required notice and public comment period. The ruling may be short-lived as new rules on contraceptive coverage from the administration are set to take effect next month. (Associated Press)

Four Democratic Senators introduced a bill that would block drug price increases that the federal government decides are unjustified. It would allow the Department of Health and Human Services to prohibit drug price increases that it deems excessive. (Reuters)